Skip to content

Clinical trials

Papillomavirus Infections trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Papillomavirus Infections Country / region: China Clear all

61 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20081
20091
20112
20141
20151
20162
20181
20196
20206
20218
202212
20237
20244
20253
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Unknown status17
Active, not recruiting11
Not yet recruiting7
Recruiting7
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fujian Maternity and Child Health Hospital7
Shanghai Bovax Biotechnology Co., Ltd.7
Shanghai Zerun Biotechnology Co.,Ltd6
Beijing Health Guard Biotechnology, Inc4
GlaxoSmithKline4
Merck Sharp & Dohme LLC4
National Vaccine and Serum Institute, China4
Lei Li3
Peking University People's Hospital3
Peking Union Medical College Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Papillomavirus Infections61
Uterine Cervical Neoplasms22
Condylomata Acuminata12
Uterine Cervical Dysplasia12
Squamous Intraepithelial Lesions11
Vaginal Neoplasms7
Vulvar Neoplasms6
Anus Neoplasms3
Adenocarcinoma in Situ2
Atypical Squamous Cells of the Cervix2

Trials

Showing 1 to 25 of 61. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.